Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach.

Mallayasamy S, Chaturvedula A, Fossler MJ, Sale ME, Hendrix CW, Haberer JE.

Front Pharmacol. 2019 Jul 12;10:785. doi: 10.3389/fphar.2019.00785. eCollection 2019.

2.

Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa.

Mallayasamy S, Chaturvedula A, Fossler MJ, Sale M, Goti V, Bumpus NN, Marzinke MA, Hendrix CW, Haberer JE; Partners Demonstration Project Team.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00446-19. doi: 10.1128/AAC.00446-19. Print 2019 Aug.

3.

Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach.

Sridharan K, Sannala CKR, Mallayasamy S, Chaturvedula A, Kadam P, Hase N, Shukla A, Gogtay N, Thatte U.

Indian J Pharmacol. 2019 Jan-Feb;51(1):17-24. doi: 10.4103/ijp.IJP_230_16.

4.

A Systematic Evaluation of Effect of Adherence Patterns on the Sample Size and Power of a Clinical Study.

Mallayasamy S, Chaturvedula A, Blaschke T, Fossler MJ.

CPT Pharmacometrics Syst Pharmacol. 2018 Dec;7(12):818-828. doi: 10.1002/psp4.12361. Epub 2018 Oct 28.

5.

Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications.

Haghighatpanah M, Nejad ASM, Haghighatpanah M, Thunga G, Mallayasamy S.

Osong Public Health Res Perspect. 2018 Aug;9(4):167-174. doi: 10.24171/j.phrp.2018.9.4.05.

6.

Direct costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital.

Kamat N, Pai G, Mallayasamy SR, Kamath A, S R.

Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):315-320. doi: 10.1080/14737167.2018.1386560. Epub 2017 Oct 12.

PMID:
29022830
7.

Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients.

Mateti UV, Nagappa AN, Attur RP, Bairy M, Nagaraju SP, Mallayasamy S, Vilakkathala R, Guddattu V, Balkrishnan R.

Saudi Pharm J. 2015 Nov;23(6):621-5. doi: 10.1016/j.jsps.2015.01.022. Epub 2015 Feb 4.

8.

Implementation and Assessment of Periodic Safety Update Reporting System at Tertiary Care Teaching Hospital, Karnataka, India: A Drug Controller General of India Initiative.

Lokhande AK, Unnikrishnan MK, Prabhu MM, Thunga G, Mallayasamy SR.

Value Health. 2014 Nov;17(7):A793. doi: 10.1016/j.jval.2014.08.447. Epub 2014 Oct 26. No abstract available.

9.

Role of Corticosteroids Use in Ards: Comparison of Systematic Review and Meta-Analysis.

Singh A, Pariti B, Mallayasamy SR, K V, Thunga G.

Value Health. 2014 Nov;17(7):A726. doi: 10.1016/j.jval.2014.08.056. Epub 2014 Oct 26. No abstract available.

10.

The Study on the Prescribing Pattern of Acinetobacter Infection in a Tertiary Care Hospital.

Vilakkathala R, Sudhapalli V, Kanad D, Mallayasamy S.

Value Health. 2014 Nov;17(7):A685-6. doi: 10.1016/j.jval.2014.08.2565. Epub 2014 Oct 26. No abstract available.

11.

Study On Drug Utilization And Assessment Of Stroke Risk Using Chads2 And Cha2ds2-Vasc Scoring In Elderly Patients With Non-Valvular Atrial Fibrillation.

Raj T, Bonthu S, Mallayasamy SR.

Value Health. 2014 Nov;17(7):A476. doi: 10.1016/j.jval.2014.08.1364. Epub 2014 Oct 26. No abstract available.

12.

Assessment of Validity of An Indicator Module In Identification of adverse Drug Events in Patients of Medicine Department.

Mallayasamy S, Shravya J, Mehta A, Vilakkathala R.

Value Health. 2014 Nov;17(7):A425-6. doi: 10.1016/j.jval.2014.08.1063. Epub 2014 Oct 26. No abstract available.

13.

The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.

Munisamy M, Tripathi M, Behari M, Raghavan S, Jain DC, Ramanujam B, Arumugam K, Rajakannan T, Mallayasamy SR, Subbiah V.

Mol Diagn Ther. 2013 Oct;17(5):319-26. doi: 10.1007/s40291-013-0041-8.

PMID:
23749495
14.

Pattern of Angiotensin-converting enzyme inhibitors induced adverse drug reactions in South Indian teaching hospital.

Mateti UV, Nekkanti H, Vilakkathala R, Rajakannan T, Mallayasamy S, Ramachandran P.

N Am J Med Sci. 2012 Apr;4(4):185-9. doi: 10.4103/1947-2714.94945.

15.

Predictors of warfarin-induced bleeding in a South Indian cardiology unit.

Nekkanti H, Mateti UV, Vilakkathala R, Rajakannan T, Mallayasamy S, Padmakumar R.

Perspect Clin Res. 2012 Jan;3(1):22-5. doi: 10.4103/2229-3485.92303.

16.

High performance liquid chromatographic fluorescence detection method for the quantification of rivastigmine in rat plasma and brain: application to preclinical pharmacokinetic studies in rats.

Arumugam K, Chamallamudi M, Mallayasamy S, Mullangi R, Ganesan S, Jamadar L, Ranjithkumar A, Udupa N.

J Young Pharm. 2011 Oct;3(4):315-21.

17.

Cost of adverse drug reactions in a South Indian tertiary care teaching hospital.

Rajakannan T, Mallayasamy S, Guddattu V, Kamath A, Vilakkthala R, Rao PG, Bairy LK.

J Clin Pharmacol. 2012 Apr;52(4):559-65. doi: 10.1177/0091270011398867. Epub 2011 Apr 19.

PMID:
21505086
18.

A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva: application to plasma-saliva correlation in epileptic patients.

Mallayasamy SR, Arumugamn K, Jain T, Rajakannan T, Bhat K, Gurumadhavrao P, Devarakonda R.

Arzneimittelforschung. 2010;60(10):599-606. doi: 10.1055/s-0031-1296332.

PMID:
21125809
19.

Development of indicators for identifying adverse drug events in an Indian tertiary care teaching hospital.

Thiyagu R, Mallayasamy SR, Rajesh V, Muralidhar V, Smitha P, Sudha V, Laxminarayana BK.

Drug Healthc Patient Saf. 2010;2:95-100. Epub 2010 Jun 30.

20.

Gender differences in the pharmacokinetics of rivastigmine in rats.

Arumugam K, Chamallamudi MR, Mallayasamy SR, Ganesan S, Shavi GV, Averineni R, Reddy R, Bhat K, Udupa N.

Arzneimittelforschung. 2009;59(10):493-7. doi: 10.1055/s-0031-1296432.

PMID:
19998576
21.

A study of rivastigmine liposomes for delivery into the brain through intranasal route.

Arumugam K, Subramanian GS, Mallayasamy SR, Averineni RK, Reddy MS, Udupa N.

Acta Pharm. 2008 Sep;58(3):287-97. doi: 10.2478/v10007-008-0014-3.

PMID:
19103565

Supplemental Content

Loading ...
Support Center